1-Benzyl-indole-3-carbinol is a highly potent new small molecule inhibitor of Wnt/&bgr;-catenin signaling in melanoma cells that coordinately inhibits cell proliferation and disrupts expression of microphthalmia-associated transcription factor isoform-M

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Carcinogenesis

• Publication date

  2017-12-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/carcin/bgx103PMID 29028954PMCID PMC5862306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Indole‐3‐carbinol (I3C) analogues are potent small molecule inhibitors of NEDD4‐1 ubiquitin ligase activity that disrupt proliferation of human melanoma cells

  2017cited by this paper
• Inhibition of oncogenic BRAF activity by indole‐3‐carbinol disrupts microphthalmia‐associated transcription factor expression and arrests melanoma cell proliferation

  2017cited by this paper
• Notch and Wnt signaling pathway in cancer: Crucial role and potential therapeutic targets (Review).

  2016cited by this paper
• In the Wnt-er of life: Wnt signalling in melanoma and ageing

  2016cited by this paper
• Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance

  2016cited by this paper
• MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells

  2015cited by this paper
• The MITF family of transcription factors: Role in endolysosomal biogenesis, Wnt signaling, and oncogenesis.

  2015cited by this paper
• Genotyping of cutaneous melanoma.

  2014cited by this paper
• WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.

  2014cited by this paper
• The Antiproliferative Response of Indole-3-Carbinol in Human Melanoma Cells Is Triggered by an Interaction with NEDD4-1 and Disruption of Wild-Type PTEN Degradation

  2014cited by this paper
• The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma.

  2014cited by this paper
• Evaluating Melanoma Drug Response and Therapeutic Escape with Quantitative Proteomics*

  2014cited by this paper
• Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells

  2014cited by this paper
• Targeting the Wnt pathways for therapies

  2014cited by this paper
• A melanocyte lineage program confers resistance to MAP kinase pathway inhibition

  2013cited by this paper
• Wnt signaling in skin development, homeostasis, and disease.

  2013cited by this paper
• Chemoprevention of skin melanoma: facts and myths

  2013cited by this paper
• OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis.

  2013cited by this paper
• A landscape of driver mutations in melanoma.

  2012cited by this paper
• Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma

  2012cited by this paper
• WNT signalling pathways as therapeutic targets in cancer

  2012cited by this paper
• Target protein interactions of indole‐3‐carbinol and the highly potent derivative 1‐benzyl‐I3C with the C‐terminal domain of human elastase uncouples cell cycle arrest from apoptotic signaling

  2012cited by this paper
• Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma

  2012cited by this paper
• Wnt/beta-Catenin Signaling and Small Molecule Inhibitors

  2012cited by this paper
• Novel targets for detection of cancer and their modulation by chemopreventive natural compounds.

  2012cited by this paper
• β-Catenin Signaling Increases during Melanoma Progression and Promotes Tumor Cell Survival and Chemoresistance

  2011cited by this paper
• Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells.

  2011cited by this paper
• Indole-3-carbinol (I3C)-induced apoptosis in nasopharyngeal cancer cells through Fas/FasL and MAPK pathway

  2011cited by this paper
• β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.

  2011cited by this paper
• Indole-3-carbinol inhibits prostate cancer cell migration via degradation of beta-catenin.

  2011cited by this paper
• Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.

  2011cited by this paper
• Indole-3-Carbinol Triggers Aryl Hydrocarbon Receptor-dependent Estrogen Receptor (ER)α Protein Degradation in Breast Cancer Cells Disrupting an ERα-GATA3 Transcriptional Cross-Regulatory Loop

  2010cited by this paper
• Direct inhibition of elastase activity by indole-3-carbinol triggers a CD40-TRAF regulatory cascade that disrupts NF-kappaB transcriptional activity in human breast cancer cells.

  2010cited by this paper
• 1-Benzyl-indole-3-carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells.

  2010cited by this paper
• Anticancer properties of indole compounds: mechanism of apoptosis induction and role in chemotherapy.

  2010cited by this paper
• Minireview: modulation of hormone receptor signaling by dietary anticancer indoles.

  2009cited by this paper
• Cellular signaling perturbation by natural products.

  2009cited by this paper
• Wnt/beta-catenin signaling: components, mechanisms, and diseases.

  2009cited by this paper
• Indole‐3‐carbinol inhibits MDA‐MB‐231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity

  2009cited by this paper
• WNT5A Expression Increases during Melanoma Progression and Correlates with Outcome

  2008cited by this paper
• The dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing

  2008cited by this paper
• Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF

  2008cited by this paper
• Indole-3-carbinol - induced growth inhibition can be converted to a cytotoxic response in the presence of TPA+Ca(2+) in squamous cell carcinoma cell lines.

  2007cited by this paper
• Indole‐3‐carbinol – Induced growth inhibition can be converted to a cytotoxic response in the presence of TPA + Ca2+ in squamous cell carcinoma cell lines

  2007cited by this paper
• MITF: master regulator of melanocyte development and melanoma oncogene.

  2006cited by this paper
• Molecular Targets and Anticancer Potential of Indole-3-Carbinol and Its Derivatives

  2005cited by this paper
• Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

  2005cited by this paper
• Wnt signalling in stem cells and cancer

  2005cited by this paper
• A Wnt-er Wonderland—The complexity of Wnt signaling in melanoma

  2005cited by this paper
• Indole-3-Carbinol (I3C) Inhibits Cyclin-dependent Kinase-2 Function in Human Breast Cancer Cells by Regulating the Size Distribution, Associated Cyclin E Forms, and Subcellular Localization of the CDK2 Protein Complex*

  2005cited by this paper
• Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features

  2003cited by this paper
• A role for Wnt signalling in self-renewal of haematopoietic stem cells

  2003cited by this paper
• Indole-3-carbinol and 3-3'-diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions.

  2003cited by this paper
• β-Catenin–induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor

  2002cited by this paper
• Functional Characterization of Multiple Transactivating Elements in β-Catenin, Some of Which Interact with the TATA-binding Proteinin Vitro *

  1999cited by this paper
• β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

  1999cited by this paper
• Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma.

  1999cited by this paper
• beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

  1999cited by this paper
• Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

  1999cited by this paper
• β‐catenin signaling and cancer

  1999cited by this paper
• beta-catenin signaling and cancer.

  1999cited by this paper
• β-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer

  1999cited by this paper
• Modulation of Transcriptional Regulation by LEF-1 in Response to Wnt-1 Signaling and Association with β-Catenin

  1998cited by this paper

• Research Progress of Natural Compounds from Chinese Herbal Medicine in the Treatment of Melanoma

  2025cites this paper
• Novel inhibitors of oncogenic Wnt/TCF-4/β-catenin signaling pathway: Design, synthesis, molecular docking studies and apoptosis inducing activity of pyrimidothiazino-, dihydropyrimidotriazepino- and 1,3,4-thiadiazolopyrimido-indole hybrids.

  2025cites this paper
• Solvent effects on the structural, spectroscopic, electronic properties, NCI-RDG analysis molecular docking and molecular dynamics studies of 1-benzyl-indole-3-carbinol

  2024cites this paper
• Heating conversion of indole-3-carbinol into N-substituted oligomers with anti-melanoma effect

  2024cites this paper
• Nanodelivery Approaches of Phytoactives for Skin Cancers: Current and Future Perspectives.

  2024cites this paper
• Indole-3-Carbinol Promotes Apoptosis and Inhibits the Metastasis of Esophageal Squamous Cell Carcinoma by Downregulating the Wnt/β-Catenin Signaling Pathway

  2024cites this paper
• Recent Development in the Search for Epidermal Growth Factor Receptor (EGFR) Inhibitors based on the Indole Pharmacophore.

  2023cites this paper
• Targeting oncogenic transcription factors in skin malignancies: An update on cancer stemness and therapeutic outcomes.

  2022cites this paper
• Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity.

  2021cites this paper
• Small Molecule Wnt Pathway Modulators from Natural Sources: History, State of the Art and Perspectives

  2020influential citation
• MicroRNA‐329 upregulation impairs the HMGB2/β‐catenin pathway and regulates cell biological behaviors in melanoma

  2019cites this paper
• The 308-nm excimer laser stimulates melanogenesis via the wnt/β-Catenin signaling pathway in B16 cells

  2019cites this paper
• Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.

  2019cites this paper
• Lycorine inhibits melanoma cell migration and metastasis mainly through reducing intracellular levels of β‐catenin and matrix metallopeptidase 9

  2018cites this paper